Tue12062022

Last updateMon, 05 Dec 2022 4pm

Back You are here: Inicio Biology & biomedicine Technological offers

New drug composition for uveal melanoma developed

CSIC has developed a pharmaceutical composition to treat uveal melanoma, a cancer that forms from melanin-producing cells in the eye. Although it has a low incidence, it is the most common eye cancer in adults. There are a few standard treatments for the primary tumour, but not for metastatic uveal melanoma of the eye.

Read more ...

Scientists develop the first portable magnetic resonance device

A team from the Institute of Instrumentation for Molecular Imaging (i3M), a joint centre of the CSIC and the Polytechnic University of Valencia, has developed the first portable magnetic resonance imaging. It is a low-cost device that can be used in situations where this diagnostic technique is usually ruled out for technical or economical reasons.

Read more ...

A biomarker signature for predicting response to cancer immunotherapy

The CSIC has developed, together with other institutions, a method to personalise therapeutic strategies combined with immune checkpoint inhibitors (ICIs) in cancer patients. It is based on 10 biomarkers, and facilitates the optimisation of therapeutic strategies for various types of tumours.

Read more ...

FlyGear, a robotic device for monitoring insects automatically and accurately

The CSIC and the Miguel Hernández University have developed a robot and its software for counting and measuring, in an automated, precise and reliable way, the transition time between life stages of fruit flies and other insects.

Read more ...

Patented molecules that counteract the effect of the most common anticoagulant drug

Researchers at IQAC-CSIC have successfully tested molecules that reverse the effect of the anticoagulant heparin, used to treat patients at risk of thrombosis. These new molecules have been patented. Patients treated with heparin may need to block its effect during surgery. The only drug available nowadays has a high molecular weight and may have associated side effects.

Read more ...